Edition:
United States

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

18.21USD
7 Dec 2018
Change (% chg)

$-0.70 (-3.70%)
Prev Close
$18.91
Open
$18.74
Day's High
$19.20
Day's Low
$18.05
Volume
923,652
Avg. Vol
876,055
52-wk High
$32.99
52-wk Low
$12.80

Chart for

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease... (more)

Overall

Beta: 3.42
Market Cap(Mil.): $2,126.27
Shares Outstanding(Mil.): 125.07
Dividend: --
Yield (%): --

Financials

  ACAD.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.44 -- --
ROI: -59.67 0.60 13.80
ROE: -59.82 -2.18 15.29

Earnings vs. Estimates